Microsatellite mutations are useful markers of both tumor clonality and genomic instability but the origin of the mutator mutations responsible is still not well understood (pages 676–681).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Spontaneous mutations in the single TTN gene represent high tumor mutation burden
npj Genomic Medicine Open Access 14 January 2020
-
A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients
Journal of Cancer Research and Clinical Oncology Open Access 25 October 2016
-
Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation
British Journal of Cancer Open Access 06 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Streisinger, G. et al. Frameshift mutations and the genetic code. Cold Spring Harbor Symp. Quant. Biol. 31, 77–84 (1966).
Marra, G. & Boland, C.R. Hereditary nonpolyposis colorectal cancer (HNPCC): The syndrome, the genes, and historical perspectives. J. Natl. Cancer Institute 87, 1114–1125 (1995).
Ionov, Y., Peinado, M.A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558–561 (1993).
Loeb, L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991).
Shibata, D., Navidi, W., Salovaara, R., Li, Z-H. & Aaltonen, L.A. Somatic microsatellite mutations as molecular tumor clocks. Nature Med. 2, 676–681 (1996).
Shibata, D., Peinado, M.A., Ionov, Y., Malkhosyan, S. & Perucho, M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet. 6, 273–281 (1994).
Markowitz, S.J. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338 (1995).
Knudson, A.G. Hereditary cancer, oncogenes and antioncogenes. Cancer Res. 45, 1437–1443 (1985).
Perucho, M. et al. Defects in replication fidelity of simple repeated sequences reveal a new mutator mechanism for oncogenesis. Cold Spring Harbor Symps. Quant. Biol. 59, 339–348 (1994).
Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
Casares, S., Ionov, Y., Ge, H.-Y., Stanbridge, E. & Perucho, M. The microsatellite mutator phenotype of colon cancer cells is often recessive, Oncogene 11, 2303–2310 (1995).
Nowell, P. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
de Wind, N., Dekker, M., Berns, A., Radman, M. & te Riele, H. Inactivation of the mouse MSH2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82, 321–330 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perucho, M. Microsatellite instability: The mutator that mutates the other mutator. Nat Med 2, 630–631 (1996). https://doi.org/10.1038/nm0696-630
Issue Date:
DOI: https://doi.org/10.1038/nm0696-630
This article is cited by
-
Spontaneous mutations in the single TTN gene represent high tumor mutation burden
npj Genomic Medicine (2020)
-
A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients
Journal of Cancer Research and Clinical Oncology (2017)
-
Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation
British Journal of Cancer (2015)
-
Microsatellite instability: an update
Archives of Toxicology (2015)
-
DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability
BMC Cancer (2014)